Skip to main content
Pharmena S.A. logo

Pharmena S.A. — Investor Relations & Filings

Ticker · PHR ISIN · PLPHRMN00011 LEI · 259400RHT936BBKW0955 WAR Manufacturing
Open in API
Filings indexed 649 across all filing types
Latest filing 2021-03-30 AGM Information
Country PL Poland
Listing WAR PHR

About Pharmena S.A.

https://www.pharmena.eu/

Pharmena S.A. is a specialty healthcare company focused on the development and commercialization of innovative products based on its patented active ingredient, 1-MNA. This molecule is a naturally occurring metabolite of niacin (vitamin B3) that plays a crucial role in cellular metabolism. The company's technology leverages the ability of 1-MNA to optimize the levels of the coenzyme NAD+, which decline with age and are vital for cellular function and regeneration. The product portfolio includes specialized cosmeceuticals, such as the Dermena line for hair loss, and dietary supplements designed to address the effects of cellular aging.

Recent filings

Filing Released Lang Actions
Treść uchwały podjętej przez NWZ PHARMENA S.A. w dniu 30 03 2021
AGM Information Classification · 99% confidence The document text is titled 'Uchwała podjęta przez Nadzwyczajne Walne Zgromadzenie' (Resolution adopted by the Extraordinary General Meeting) and specifically details a resolution regarding changes in the composition of the Supervisory Board ('zmian w składzie Rady Nadzorczej'). This content directly relates to the formal proceedings and outcomes of a shareholder meeting, specifically concerning governance structure changes. This aligns best with the 'AGM Information' (AGM-R) category, as Extraordinary General Meetings (EGMs) fall under the scope of general meetings, even if the specific resolution is about board composition, which could sometimes overlap with MANG or CGR, but the context of being a formal 'Uchwała' from a 'Walne Zgromadzenie' points strongly to AGM-R. Since the document contains the actual resolution and voting results, it is the meeting material itself, not just an announcement of it.
2021-03-30 Polish
Treść uchwał podjętych przez NWZ PHARMENA S.A. w dniu 30.03.2021 r. - Content (PL)
AGM Information Classification · 99% confidence The document text explicitly mentions the content of resolutions ('treść uchwał') passed at an Extraordinary General Meeting ('Nadzwyczajnego Walnego Zgromadzenia') held on March 30, 2021. This directly relates to the outcomes of a shareholder meeting. While it concerns resolutions, the context is the announcement of the results of a vote taken at a general meeting, which aligns best with the Declaration of Voting Results & Voting Rights Announcements (DVA). It is not the AGM presentation itself (AGM-R) nor a general proxy solicitation (PSI). Given the short length and the focus on announcing the resolutions passed, DVA is the most precise fit.
2021-03-30 Polish
Udzielenie patentu w Federacji Rosyjskiej - Content (PL)
Regulatory Filings Classification · 100% confidence The document text is very short (903 characters) and announces a specific event: the granting of a patent (nr 2744615) by the Russian Patent Office for the use of 1-MNA. It explicitly states that this information is being disclosed because it may affect the valuation of the company's assets (patents and applications). This is a specific, material announcement that does not fit the definitions for standard financial reports (10-K, IR, ER) or common corporate actions (DIV, MANG, DIRS). Since it is a specific regulatory/material disclosure that doesn't fit the highly specific categories like LTR (Legal Proceedings) or CAP (Financing), the most appropriate general category for material, non-standard announcements is Regulatory Filings (RNS).
2021-03-29 Polish
210329_PHR_Notka biograficzna_kandydat na członka RN_A. Janicka
Board/Management Information Classification · 95% confidence The document text details the professional qualifications, education, and employment history of an individual named Pani Anna Janicka, including roles such as Financial Director and Board Member. This type of biographical information, especially concerning senior personnel, is characteristic of filings related to Board/Management changes or Governance. Given the specific focus on management roles and qualifications, the most appropriate category is Board/Management Information (MANG). It is not a formal financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2021-03-29 Polish
Oświadczenie o niezależności_A.Janicka
Governance Information Classification · 98% confidence The document text is titled "OŚWIADCZENIE O NIEZALEŻNOŚCI I SPEŁNIENIU WYMAGAŃ OCZEKIWANYCH OD CZŁONKA KOMITETU AUDYTU" (Declaration of Independence and Fulfillment of Requirements Expected from an Audit Committee Member). This document is a formal declaration used to assess the independence of a member of the Audit Committee, typically required by corporate governance regulations, especially concerning auditors and committee members. This directly relates to internal rules, board structure, and governance practices, making it a Governance Information document. It is not an Annual Report (10-K), an Audit Report (AR), a Remuneration Report (DEF 14A), or a general Investor Presentation (IP). The closest fit among the provided codes is Governance Information (CGR).
2021-03-29 Polish
Oświadczenie_kandydata_na czlonka_RN_A.Janicka
Board/Management Information Classification · 98% confidence The document is titled "Oświadczenie kandydata na Członka Rady Nadzorczej Spółki Pharmena S.A." which translates to "Statement of the candidate for the Member of the Supervisory Board of Pharmena S.A.". The content is a formal declaration by an individual (Anna Janicka) consenting to be nominated and appointed to the Supervisory Board, confirming compliance with legal requirements (like not being in a competing company or the Register of Insolvent Debtors). This type of document directly relates to the composition and governance structure of the company's board. This aligns best with the 'Board/Management Information' category (MANG), which covers announcements of changes in the board of directors or senior management, as this is a prerequisite document for such a change.
2021-03-29 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.